Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wencker

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|April 28, 1999
[Augmentation therapy with human alpha 1-protease inhibitor: whom to treat when?]M Wencker
Respiratory Medicine|August 23, 2000
Screening for alpha1-Pi deficiency in patients with lung diseasesM Wencker
Respiratory Medicine|February 24, 2001
Blood gases at rest and during exercise in patients with alpha1-Pi deficiencyM Wencker, N Konietzko
Respiration; International Review of Thoracic Diseases|January 1, 1994
Serial measurements of FEV1 over 12 years in a patient with alpha-1-protease inhibitor deficiency:influence of augmentation therapy and infectionsM Wencker, J Denker, N Konietzko
Clinical Chemistry|July 1, 1989
Influence of blood pressure, heart rate, age, and sex on concentrations of atrial natriuretic factor and cyclic GMP in 124 volunteersM Wencker, S Hauptlorenz, W Moll, et al.
The Thoracic and Cardiovascular Surgeon|August 1, 1994
Omentopexy and muscle transposition: two alternative methods in the treatment of pleural empyema and mediastinitisG Stamatis, L Freitag, M Wencker, et al.
Deutsche Medizinische Wochenschrift (1946)|May 25, 2006
[Guideline conformance for outpatient management of COPD in Germany]T Glaab, N Banik, C Singer, et al.
JAMA|December 1, 1989
Influence of beta-blockade on ejection fraction, ANP, and cGMP in patients after myocardial infarctionS Hauptlorenz, B Puschendorf, M Wencker, et al.
Chest|March 13, 2001
Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitorM Wencker, B Fuhrmann, N Banik, et al.
Pneumologie (Stuttgart, Germany)|June 14, 2012
[Rare diseases in pulmonary medicine and its challenges]M Wencker, H Teschler, C Vogelmeier, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Medizinische Klinik (Munich, Germany : 1983)|April 28, 1999
[Augmentation therapy with human alpha 1-protease inhibitor: whom to treat when?]M Wencker
Respiratory Medicine|August 23, 2000
Screening for alpha1-Pi deficiency in patients with lung diseasesM Wencker
Respiratory Medicine|February 24, 2001
Blood gases at rest and during exercise in patients with alpha1-Pi deficiencyM Wencker, N Konietzko
Respiration; International Review of Thoracic Diseases|January 1, 1994
Serial measurements of FEV1 over 12 years in a patient with alpha-1-protease inhibitor deficiency:influence of augmentation therapy and infectionsM Wencker, J Denker, N Konietzko
Clinical Chemistry|July 1, 1989
Influence of blood pressure, heart rate, age, and sex on concentrations of atrial natriuretic factor and cyclic GMP in 124 volunteersM Wencker, S Hauptlorenz, W Moll, et al.
The Thoracic and Cardiovascular Surgeon|August 1, 1994
Omentopexy and muscle transposition: two alternative methods in the treatment of pleural empyema and mediastinitisG Stamatis, L Freitag, M Wencker, et al.
Deutsche Medizinische Wochenschrift (1946)|May 25, 2006
[Guideline conformance for outpatient management of COPD in Germany]T Glaab, N Banik, C Singer, et al.
JAMA|December 1, 1989
Influence of beta-blockade on ejection fraction, ANP, and cGMP in patients after myocardial infarctionS Hauptlorenz, B Puschendorf, M Wencker, et al.
Chest|March 13, 2001
Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitorM Wencker, B Fuhrmann, N Banik, et al.
Pneumologie (Stuttgart, Germany)|June 14, 2012
[Rare diseases in pulmonary medicine and its challenges]M Wencker, H Teschler, C Vogelmeier, et al.
Pageof 4